MIMETAS is microfluidics company founded in 2013. MIMETAS develops Organ-on-a-Chip technology for testing of new medicines. Its unique microfluidic technology enables testing of new medicines in high-throughput in miniaturized organ models. These models show better predictability compared to laboratory animals and conventional cell culture models. MIMETAS boasts a unique prototyping and production platform, a world-leading position in passive microfluidics and a unique value proposition based on proprietary OrganoPlate® technology. OrganoPlates® are based on a proprietary microfluidic liquid handling technique called PhaseGuides™, enabling membrane-free in vitro 3D co-culture models with continuous perfusion. OrganoPlates®-based models as under development for a large variety of tissues and diseases. The design of the OrganoPlate® is based on a microtiter plate and thus compatible with standard robot and readout equipment, making the technology suitable for high‐throughput automation.
JH Oortweg 19
Leiden, Zuid-Holland 2333CH
Categories: Cell Culture, Cell Culture Apparatus/Supplies